MiMedx Group, Inc - Common Stock (NQ:MDXG)

3.880 -0.090 (-2.27%)

Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MiMedx Group, Inc - Common Stock

< Previous 1 2 3 4 Next >

MiMedx (MDXG) Q3 2026 Earnings Call Transcript ↗

October 29, 2026

Surgical revenue grew 9% despite 45% net sales decline from Medicare changes.

Via The Motley Fool

Topics Earnings Intellectual Property

What MiMedx Group (MDXG) Said on Its Q3 Earnings Call ↗

October 28, 2026

MiMedx Group (NASDAQ:MDXG) reported third-quarter net sales of $62 million, down 45% from a year earlier, as continued disruption in the wound care market offset growth in its surgical business. The...

Via MarketBeat

Topics Earnings

MiMedx (MDXG) Q2 2026 Earnings Call Transcript ↗

August 07, 2026

Surgical revenue grew 15% as wound care stabilized ahead of $350M Sanara deal.

Via The Motley Fool

Topics Earnings

MIMEDX Group (NASDAQ:MDXG) Shares Fall After Q2 Revenue and EPS Slightly Miss Estimates ↗

July 29, 2026

Via Chartmill

MiMedx Group (NASDAQ:MDXG) Posts Disappointing Q1 Results, Stock Tumbles 8% After-Hours ↗

April 29, 2026

Via Chartmill

MIMEDX Group Inc (NASDAQ:MDXG) Stock Dips Despite Strong Earnings Beat ↗

February 25, 2026

Via Chartmill

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ), Sanara MedTech Inc. (Nasdaq – SMTI), TriCo Bancshares (Nasdaq – TCBK)

August 04, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

MiMedx Group Q2 Earnings Call Highlights ↗

July 29, 2026

MiMedx Group (NASDAQ:MDXG) said it has agreed to acquire Sanara MedTech in a transaction valued at $35 per Sanara share, a deal the company expects to close by the end of 2026. The announcement...

Via MarketBeat

Topics Earnings

Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself

June 18, 2026

From Biotech Insider

Via GlobeNewswire

Earnings Scheduled For October 29, 2025 ↗

October 29, 2025

Via Benzinga

Earnings Scheduled For July 30, 2025 ↗

July 30, 2025

Via Benzinga

Earnings Scheduled For April 30, 2025 ↗

April 30, 2025

Via Benzinga

A Peek at MiMedx Group's Future Earnings ↗

April 29, 2025

Via Benzinga

The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It

June 16, 2026

From World Street Intelligence

Via GlobeNewswire

A Fresh FDA Catalyst Is Putting Regenerative Wound Care in Focus

June 09, 2026

Issued on behalf of Conexeu Sciences Inc.

From Equity Insider

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

May 19, 2026

From Pomerantz LLP

Via GlobeNewswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MiMedx Group, Inc. - MDXG

May 12, 2026

From Pomerantz LLP

Via GlobeNewswire

TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues

April 30, 2026

From TELA Bio, Inc.

Via GlobeNewswire

What's going on in today's after hours session ↗

April 29, 2026

Via Chartmill

MiMedx (MDXG) Q4 2025 Earnings Call Transcript ↗

February 25, 2026

MiMedx (MDXG) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

MDXG Stock Rises As MiMedx Enters Into Exclusive Distribution Agreement For Three Products ↗

February 04, 2026

According to the agreement, Summit Products Group will distribute Hydrelix, NovaForm, and G4Derm Plus, designed to complement MiMedx’s portfolio of leading surgical and wound products.

Via Stocktwits

Topics Artificial Intelligence

What's going on in today's after hours session ↗

November 17, 2025

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

MiMedx (MDXG) Q3 2025 Earnings Call Transcript ↗

October 30, 2025

MiMedx (MDXG) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

MIMEDX GROUP INC (NASDAQ:MDXG) Reports Record Q2 2025 Earnings, Surpassing Estimates and Driving Stock Surge ↗

July 30, 2025

MIMEDX Group (MDXG) reports record Q2 2025 earnings, beating revenue and EPS estimates with $98.61M in sales and $0.10 EPS. Stock surges 11.8% post-announcement.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 30, 2025

Via Benzinga

Wednesday's after hours session: top gainers and losers ↗

July 30, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

July 15, 2025

Via Benzinga

Why Trade Desk Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗

July 15, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 14, 2025

Via Benzinga

Get insights into the top gainers and losers of Monday's after-hours session. ↗

July 14, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.